Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Mankind Pharma has informed that the management and officials of the Company will participate in below conference and investor meetings: (i) Jefferies 5th Asia Forum/ Investor Conference - scheduled on 19th and 20th March 2024 in Hong Kong and (ii) meetings with various investors scheduled on 21st and 22nd March 2024 in Singapore. No Unpublished Price Sensitive Information will be shared at the aforesaid conference/ investor meetings.
The above information is a part of company’s filings submitted to BSE.
